Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #135, February 2019
A Pennsylvania state jury awarded $41 million to a couple in a transvaginal mesh case after determining that Ethicon Inc. and its parent Johnson & Johnson negligently manufactured their Prolift, TVT-O and GyneMesh polypropylene mesh devices.
Various physicians, medical spas and weight loss clinics across the country have sued CynoSure Inc. in Massachusetts federal court, alleging its “body-contouring” SculpSure device did not perform as marketed, causing the plaintiffs to incur substantial damages.
An Indiana federal judge has ruled that a tag-along action filed in the Biomet M2a Magnum Hip multidistrict litigation should be transferred to the Western District of Texas, where the plaintiff’s injury manifested, and his revision surgery occurred.
Retrial of a case targeting DePuy’s Pinnacle hip implant has begun in Texas federal court, following the 5th Circuit U.S. Court of Appeals’ reversal of a $502 million verdict due to “serious evidentiary errors” committed by the trial court.
DePuy Orthopaedics and its parent Johnson & Johnson have agreed to pay $120 million to settle deceptive marketing claims asserted by several states involving the companies’ metal-on-metal hip implants.
An Idaho federal judge has dismissed a fraudulent misrepresentation claim in a lawsuit involving Boston Scientific Corp.’s Greenfield IVC filter, ruling that the plaintiff failed to plead her allegations with the particularity required by Rule 9(b).
A Florida federal judge has remanded an action involving NuVasive Inc.’s SpheRx spinal system, ruling that the defendant failed to prove that the amount in controversy exceeds $75,000.
A Tennessee federal judge has remanded a glucose monitoring system case for lack of federal question jurisdiction, ruling that the question of whether Dexcom Inc. complied with federal law in its manufacture and sale of the device is not a central issue to the case.
India-based drug maker Torrent Pharmaceuticals Ltd. has expanded its voluntary recall of losartan-containing drugs due to N-nitrosodiethylamine (NDEA) contamination.
A federal district court properly awarded C.R. Bard and Davol Inc. summary judgment in a hernia mesh case because the causation theory presented by the plaintiffs’ expert was not sufficiently reliable, the 7th Circuit U.S. Court of Appeals has ruled.